ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Vor Biopharma Inc

Vor Biopharma Inc (VOR)

0.95
-0.0298
(-3.04%)
Closed July 14 4:00PM
0.9405
-0.0095
(-1.00%)
After Hours: 7:41PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.9405
Bid
0.92
Ask
14.00
Volume
453,890
0.9223 Day's Range 0.9931
0.90 52 Week Range 3.48
Market Cap
Previous Close
0.9798
Open
0.98
Last Trade
6
@
0.9875
Last Trade Time
Financial Volume
$ 430,290
VWAP
0.948005
Average Volume (3m)
281,720
Shares Outstanding
68,259,602
Dividend Yield
-
PE Ratio
-0.55
Earnings Per Share (EPS)
-1.73
Revenue
-
Net Profit
-117.86M

About Vor Biopharma Inc

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker VOR. The last closing price for Vor Biopharma was $0.98. Over the last year, Vor Biopharma shares have traded in a share price range of $ 0.90 to $ 3.48.

Vor Biopharma currently has 68,259,602 shares outstanding. The market capitalization of Vor Biopharma is $66.88 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.55.

VOR Latest News

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of July 1, 2024, the...

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of June 1, 2024, the...

Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update

On-track for trem-cel and VCAR33ALLO clinical updates in the second half of 2024Trem-cel trial expanded to include patients with myelodysplastic syndromes (MDS); Mylotarg™ dosing has advanced to...

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming...

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of May 1, 2024, the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00050.05319148936170.940.99990.92279490.93665429CS
4-0.2795-22.90983606561.221.270.93007691.08442859CS
12-0.7295-43.68263473051.671.950.92817201.42180178CS
26-1.9995-68.01020408162.943.13990.92966911.80374498CS
52-2.1095-69.16393442623.053.480.92072061.96144918CS
156-18.2395-95.096454640319.1819.590.91610525.09256548CS
260-41.0795-97.761780104742.0263.620.91670299.7664492CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.65M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

Your Recent History

Delayed Upgrade Clock